$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The… Read More ›
Merck
Merck cholesterol drug fails; risks seen/ But yet approved in the European Union in since 2008
Thu, 20 Dec 2012 17:03 GMT Reuters * Cites increase in nonfatal side effects * Says it will not seek U.S. approval of high-profile drug * Failure is latest setback for HDL-raising drugs * Merck shares fall 2.5 percent (Adds… Read More ›
For Some Men, Propecia’s Sexual Side Effects May Be Long-lasting
By CARRIE GANN, ABC News Medical Unit | Good Morning America Kevin Malley was almost 30, and he was starting to lose his hair. He went to his doctor to see if there was a way to keep from going… Read More ›
Merck Accused of Faking Mumps Vaccine Data
Couthouse News Service Site 27 JUN 201 PHILADELPHIA (CN) – Merck has known for a decade that its mumps vaccine is “far less effective” than it tells the government, and it falsified test results and sold millions of doses of… Read More ›
Engineering Evil 